Science news articles about 'merck co inc'

... in the STEP trial, an investigational product developed by Merck & Co. Inc., failed to prevent HIV infection or reduce viral load. Subsequent analyses of the STEP trial found increased ...

... already targeted by a drug approved for cutaneous T-cell lymphoma manufactured by the global pharmaceutical company Merck & Co. Inc. However, UF's compound does not inhibit all HDACs ...

... as vice president of medical affairs and policy for vaccines and infectious diseases at Merck & Co., Inc. The reasons are found in significant differences in immune signaling in a specific type of ...

... and Mectizan from the programme's two key pharmaceutical partners, GlaxoSmithKline and Merck & Co., Inc. The cost-efficiency combined with the programme's achievements has prompted officials to ...

... a test-of-concept efficacy study of a Merck & Co., Inc. HIV vaccine candidate, were published ... Enterprise. "The Step study partnership among Merck, HVTN, and NIAID exemplifies the synergistic effort ...

... of ivermectin—also known as Mectizan® donated by Merck & Co., Inc. Ivermectin had been given to 85 percent of ... the six endemic countries, CDC, PAHO, Merck, Bill & Melinda Gates Foundation, and Lions ...

... time, pancreatic cancer in humans. Januvia is marketed by Merck & Co. Inc. Sitagliptin is a member of a new class of drugs that enhance the actions of the gut hormone known as glucagon-like ...

... four years before its manufacturer, Merck & Co. Inc., voluntarily pulled the drug from the market. ... 2004, a 43 percent increased risk. Merck introduced Vioxx to the market in May 1999 and the drug ...